Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation VariablesAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
World Journal of Urology|March 20, 2024
Incidence of complications and urinary incontinence following endoscopic enucleation of the prostate in men with a prostate volume of 80 ml and above: results from a multicenter, real-world experience of 2512 patientsVineet Gauhar, Daniele Castellani, Thomas R W Herrmann, et al.
Minerva Urology and Nephrology|August 5, 2020
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life studyMauro Gacci, Michele Marchioni, Piergustavo DE Francesco, et al.
European Urology Open Science|July 11, 2022
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk CalculatorSneha Parekh, Parita Ratnani, Ugo Falagario, et al.
World Journal of Urology|November 1, 2024
The infection post flexible UreteroreNoscopy (I-FUN) predictive model based on machine learning: a new clinical tool to assess the risk of sepsis post retrograde intrarenal surgery for kidney stone diseaseDaniele Castellani, Virgilio De Stefano, Carlo Brocca, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin ImmunotherapyMatteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
Frontiers in Oncology|May 23, 2022
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy RegistryGian Maria Busetto, Daniele D'Agostino, Michele Colicchia, et al.
Cancers|February 25, 2022
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched AnalysisFrancesco Del Giudice, Rocco Simone Flammia, Benjamin I Chung, et al.
BJU International|June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancerMatteo Ferro, Michele Catellani, Roberto Bianchi, et al.
Cancers|November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort AnalysisMatteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Pageof 19